Articles by Khashayar Dashtipour, MD

The director of the Movement Disorders Division at Loma Linda University discussed the importance of understanding good ON time in Parkinson disease care, and how it can influence quality of life. [WATCH TIME: 5 minutes]

Parkinson’s Disease: Advice for Community Neurologists
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Expert neurologists provide insight on how to decide on an on-demand therapy for Parkinson’s disease and provide some general advice.

Sublingual Apomorphine for Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Key opinion leaders explain the use of sublingual apomorphine and trimethobenzamide for Parkinson’s disease.

Side Effects of Apomorphine Usage in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD A panel of experts debate the disadvantages and side effects of apomorphine therapies for Parkinson’s disease.

Apomorphine Subcutaneous Injections for Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD A discussion on the use of apomorphine subcutaneous injections in managing Parkinson’s disease.

Levodopa Inhalation Powder for Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Neurologists debate the use of levodopa inhalation powder in managing Parkinson’s disease.

When to Use On-Demand Therapies in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Physicians discuss when to add on-demand therapies to Parkinson’s disease management.

Important Attributes of On-Demand Therapies for Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Key opinion leaders explain the important attributes to consider when choosing an on-demand therapy.

The Relationship Between the Gut and Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Experts debate the challenges of carbidopa/levodopa, and the relation between levodopa and the gut.

Motor and Non-Motor Symptoms in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Panelists describe the motor and non-motor symptoms of Parkinson’s disease, linking symptoms to OFF episodes, and how to educate patients.

Parkinson’s Disease: Evaluating Patients for OFF Episodes
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD A discussion on how patients are evaluated for OFF episodes, by expert neurologists.

Expected and Unexpected OFF Episodes in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Physicians explain expected versus unexpected OFF episodes and the use of symptom diaries in managing Parkinson’s disease.

Impact of Parkinson’s Disease OFF Episodes on Quality of Life
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Key opinion leaders provide insight on how OFF episodes affect patients’ quality of life.

Parkinson’s Disease: Why do OFF Episodes Occur?
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Expert neurologists discuss why OFF episodes happen and how soon they occur after starting levodopa.

OFF Episodes in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Panelists have a conversation on the definition of OFF episodes in relation to Parkinson’s disease and how common OFF episodes are for patients.